Events » Other » 2.5 Weeks to Deliver Desired Humanized Antibody in ProBio

Event Details

  • 2.5 Weeks to Deliver Desired Humanized Antibody in ProBio

    500+ Antibody Humanization Projects
    Guarantee no loss of affinity
    The most advanced project is marketed

    antibody humanization & antibody characterization can reduce the immunogenicity of monoclonal antibodies derived from xenogeneic sources and improve their activation of the human immune system by replacing non-human antibody frameworks with human ones. It is a very important step in the therapeutic antibody discovery process. ProBio is the world’s No.1 fast antibody humanization service provider, providing 2 packages for antibody humanization services.

    20-year experience in antibody discovery
    Delivered over 500 projects
    The most advanced project is marketed
    Guarantee no loss of affinity
    Humanization rate >95%
    Provide developability prediction reports including PTM, aggregation and immunogenicity.
    Various detection systems: SPR, ELISA, FACS
    Suitable for mAb, scFv and sdAb

    Service Introduction
    Express Service: As Fast as 2.5 weeks to Get Your Antibody Humanized
    Through CDR grafting and back mutation technologies, the express package can be used to produce humanized antibodies with high expression levels, good thermal stability, and comparable affinity with the parental antibodies as fast as 2.5 weeks.


    Deluxe Service: Get Humanized Antibody with No Affinity Loss
    Deluxe package can be used to obtain the humanized antibodies without affinity loss through CDR grafting, back mutation, and FASEBA high-throughput screening technology as fast as 8 weeks.

    Learn more about patented FASEBA screening platform
    FASEBA is a patented E.Coli based system that selects good affinity, expression level and thermostable candidates. It is used to select the best protein binders from a large number of protein candidates in a high throughput fashion, without actually purifying these proteins.

    Each saturation mutation library is transformed into FASEBA E.coli based expression system.

    How to Avoid Developability Risk in the Early Stage of Discovery?
    ProBio offers 3 developability assessment packages for antibody drug candidates at different discovery stages to identify the potential risks of manufacture and clinical failure.

    Service Package
    Deluxe Humanization --- Back mutaiton library screening with FASEBA

    The turnaround time listed here is the time required for the service itself. For international shipping, please refer to the time provided by PM during project discussion.

    Express plus humanization --- CDR grafting with back mutation

    The turnaround time listed here is the time required for the service itself. For international shipping, please refer to the time provided by PM during project discussion.
    Human framework diversity
    Fast turnaround time
    Guaranteed delivery of humanized abs with comparable affinity with parental abs

    Media Contact
    Company Name: ProBio CDMO
    Contact Person: ProBio CDMO
    Email:
    USA: cdmo.us@probiocdmo.com
    China: cdmo.cn@probiocdmo.com
    APAC: cdmo.apac@probiocdmo.com
    Europe: cdmo.eu@probiocdmo.com
    Japan: cdmo.jp@probiocdmo.com
    South Korea: cdmo.kr@probiocdmo.com
    Phone: (+86-22) 8758-7199 ext. 6027
    Website: https://www.probiocdmo.com/

  • 12/11/24 at 1:00 AM -
    3/12/25 at 1:00 AM
  • Category
  • click to rate

  • RSVPs
    • 1 attending
    • 0 maybe attending
    • 0 not attending
    • 0 awaiting reply

Updates

Nothing has been posted here yet - be the first!